Louisbourg Investments Inc. Sells 12,946 Shares of Agilent Technologies, Inc. $A

Louisbourg Investments Inc. lowered its stake in Agilent Technologies, Inc. (NYSE:A) by 26.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 35,874 shares of the medical research company’s stock after selling 12,946 shares during the quarter. Louisbourg Investments Inc.’s holdings in Agilent Technologies were worth $4,881,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Capital A Wealth Management LLC lifted its holdings in shares of Agilent Technologies by 10,600.0% during the 2nd quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock valued at $25,000 after buying an additional 212 shares during the period. Board of the Pension Protection Fund purchased a new stake in Agilent Technologies during the fourth quarter valued at $27,000. Davis Capital Management bought a new position in Agilent Technologies in the third quarter valued at about $28,000. Physician Wealth Advisors Inc. lifted its holdings in Agilent Technologies by 490.0% in the third quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock valued at $30,000 after acquiring an additional 196 shares during the period. Finally, State of Wyoming purchased a new position in Agilent Technologies in the second quarter worth about $35,000.

Agilent Technologies Stock Performance

Shares of A opened at $115.44 on Friday. The business has a 50-day simple moving average of $121.67 and a two-hundred day simple moving average of $134.51. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $160.27. The stock has a market cap of $32.62 billion, a price-to-earnings ratio of 25.48, a PEG ratio of 2.41 and a beta of 1.30.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). The company had revenue of $1.80 billion for the quarter, compared to analysts’ expectations of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The firm’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be issued a dividend of $0.255 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $1.02 annualized dividend and a yield of 0.9%. Agilent Technologies’s payout ratio is currently 22.52%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on A shares. UBS Group cut their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Wells Fargo & Company dropped their price objective on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a report on Thursday, February 26th. The Goldman Sachs Group assumed coverage on shares of Agilent Technologies in a research report on Tuesday, December 9th. They set a “buy” rating and a $170.00 target price for the company. TD Cowen reduced their target price on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Finally, HSBC began coverage on shares of Agilent Technologies in a research report on Tuesday, January 20th. They issued a “buy” rating and a $180.00 price target on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $161.20.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.